Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Other Non-Current Assets (2020 - 2025)

Biofrontera has reported Other Non-Current Assets over the past 6 years, most recently at $360000.0 for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $360000.0 for Q4 2025, down 6.01% from a year ago — trailing twelve months through Dec 2025 was $360000.0 (down 6.01% YoY), and the annual figure for FY2025 was $360000.0, down 6.01%.
  • Other Non-Current Assets for Q4 2025 was $360000.0 at Biofrontera, down from $472000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for BFRIW hit a ceiling of $1.4 million in Q3 2021 and a floor of $85000.0 in Q3 2022.
  • Median Other Non-Current Assets over the past 5 years was $383000.0 (2024), compared with a mean of $418411.8.
  • Biggest five-year swings in Other Non-Current Assets: plummeted 93.81% in 2022 and later skyrocketed 478.82% in 2023.
  • Biofrontera's Other Non-Current Assets stood at $268000.0 in 2021, then increased by 19.4% to $320000.0 in 2022, then skyrocketed by 50.62% to $482000.0 in 2023, then dropped by 20.54% to $383000.0 in 2024, then dropped by 6.01% to $360000.0 in 2025.
  • The last three reported values for Other Non-Current Assets were $360000.0 (Q4 2025), $472000.0 (Q3 2025), and $535000.0 (Q2 2025) per Business Quant data.